Sanofi India Reports Mixed Q3 2024 Results with Revenue Growth and Profit Decline
Sanofi India Limited announced its Q3 2024 financial results, showing a 9.8% increase in revenue to ₹5,150 million, but a 33.8% decrease in net profit to ₹913 million. EBITDA grew by 18.5% to ₹1,180 million, with the EBITDA margin improving to 22.98%. Profit Before Tax increased by 14.8% to ₹1,140 million. An exceptional item of ₹80 million was noted, potentially impacting overall profit figures.